Neuromuscular Disorders
Conference Coverage
VIDEO: Big research trials at AAN bring up important cost decisions
BOSTON – How will neurologists strike a balance between new drugs’ improved efficacy and safety and their affordability for patients?
Conference Coverage
AAN spotlights spinal muscular atrophy clinical research
A variety of sessions at this year’s annual meeting of the American Academy of Neurology in Boston will highlight efforts to treat children with...
From the Journals
Novel protein biomarker could accelerate ALS research
Researchers have shown evidence for the utility of measuring the mutated protein that is produced by a minority of ALS patients and tracking its...
Literature Review
Outpatient Visits Involving CNS Polypharmacy Rising Among Elderly
The number of outpatient visits involving CNS polypharmacy by adults aged 65 and older more than doubled between 2004 and 2013, especially among...
From the Journals
LVADs achieve cardiac palliation in muscular dystrophies
LVADs gain ground as destination therapy in muscular dystrophies.
News from the FDA/CDC
FDA approves Emflaza for Duchenne muscular dystrophy
Emflaza (deflazacort) becomes the first corticosteroid to be approved by the Food and Drug Administration for Duchenne muscular dystrophy.
Patient Information
Tips for Living With Tardive Dyskinesia
Tardive dyskinesia is a movement disorder characterized by repetitive, involuntary muscle tics. These movements may occur occasionally or...
Patient Information
Tips for Living With Suspected CTE
Chronic traumatic encephalopathy (CTE) is a progressive degenerative brain disease found in athletes, military personnel, and people with...
From the Journals
New histopathologic marker may aid dermatomyositis diagnosis
The detection of sarcoplasmic myxovirus resistance A expression in immunohistochemical analysis of muscle biopsy in patients suspected of having...
From the Journals
Meningococcal conjugate vaccination may be associated with increased risk of Bell’s palsy
Meningococcal conjugate vaccine plus another vaccine may be associated with increased risk of Bell’s palsy.
Conference Coverage
What’s New in Rare Neuromuscular Disorders?
LAS VEGAS—At the American Academy of Neurology’s Fall 2016 Conference, Robert M. Pascuzzi, MD, presented several case videos to illustrate recent...